Myeloma BCMA Therapy In Spotlight: EMA Considers Fast Tracking GSK Filing

EU Filing Understood To Be Expected in H1 2020

 
• By Neena Brizmohun
  
Running
GSK is leading the race to market a BCMA-targeting therapy for myeloma • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet